New Insights Rifamycin B Biosynthesis : Isolation of Proansamycin B and 34a-Deoxy-rifamycin W as Early Macrocyclic Intermediates Indicating Two Separated Biosynthetic Pathways

  • STRATMANN Ansgar
    Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
  • SCHUPP Thomas
    Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
  • TOUPET Christiane
    Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
  • SCHILLING Wolfgang
    Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
  • OBERER Lukas
    Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
  • TRABER Rene
    Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies

この論文をさがす

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (20)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1570572699688528512
  • NII論文ID
    10008472526
  • NII書誌ID
    AA0069330X
  • ISSN
    00218820
  • 本文言語コード
    en
  • データソース種別
    • CiNii Articles

問題の指摘

ページトップへ